Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson, Jon‐Helge Angelsen, Christina Biörserud, Bergþór Björnsson, Erling A. Bringeland, Nils Elander, Herish Garresori, Jon Erik Grønbech, Johan Haux, Oskar Hemmingsson, Maria Gustafsson Liljefors, Tor Åge Myklebust, Linn Såve Nymo, Katriina Peltola, Per Pfeiffer, Ville Sallinen, Per Sandström, Ernesto Sparrelid, Helge Stenvold, Kjetil Søreide, Bobby Tingstedt, Caroline S. Verbeke, Daniel Öhlund, Leif Klint, Svein Dueland, Kristoffer Lassen, Eirik Kjus Aahlin, Charlotte Bratthäll, Asif Halimi, Ingunn Hatlevoll, Margareta Heby, Arto Kokkola, Maximilian Kordes, Stina Lindblad, Linda Lundgren, Michael Bau Mortensen, Kim Erlend Mortensen, Jan Persson, Elena Rangelova, Elin Rønne, Oddvar M. Sandvik, Jon Arne Søreide, Caroline Vilhav, Kim Waardal, Johanna Wennerblom, Caroline Williamsson, Sheraz Yaqub